As with all therapies that have been described for GBM patients, improved tumor stratification is, in any case, necessary to reach the appropriate responsive patient subcategory especially since (albeit in a small subset of tested patients) TMZ + BMP4 sometimes has an antagonistic effect. This evidence concerns the gene BMP4 and neoplasm.